LGALS3 and neoplasm: Previously, MCP demonstrated inhibition of Gal-3 and the ability to inhibit cancer cell adhesion, homotypic aggregation, invasion, angiogenesis, and sensitization of neoplastic cells to apoptosis induced by chemotherapeutic agents, and correction of the impaired function of tumor-infiltrating lymphocytes [32].